Cite Filings / IMNM / 0000919574-26-005205

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Immunome Inc. Filed 2026-08-14 Acc 0000919574-26-005205

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-08-12 144 Sale of Securities
2026-08-12 4 Director sold 83,464 shares at an average $26.35 ($2,198,910)
2026-08-11 S-8 Securities Offered to Employees in Benefit Plans
2026-08-11 10-Q Quarterly Report
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…